Dai, L., Lin, Z., Qiao, J., Chen, Y., Flemington, E. K., & Qin, Z. (2017). Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma. Oncogene.
Citación estilo ChicagoDai, Lu, Zhen Lin, Jing Qiao, Yihan Chen, Erik K. Flemington, and Zhiqiang Qin. "Ribonucleotide Reductase Represents a Novel Therapeutic Target in Primary Effusion Lymphoma." Oncogene 2017.
Cita MLADai, Lu, et al. "Ribonucleotide Reductase Represents a Novel Therapeutic Target in Primary Effusion Lymphoma." Oncogene 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.